Human Metabolome Technologies, Inc. (TYO:6090)

TYO:6090 Revenue

In the fiscal year ending June 30, 2026, Human Metabolome Technologies had annual revenue of 1.42B JPY, down -2.34%. Human Metabolome Technologies had revenue of 314.00M in the quarter ending June 30, 2026, with 66.14% growth. That makes Human Metabolome Technologies the 37,803rd largest company in the world by revenue and 3,738th in Japan.

• Revenue: 1.42B
• Revenue Growth: -2.34%
• P/S Ratio: 2.24
• Revenue / Employee: 21.86M
• Employees: 65
• Market Cap: 3.18B

Revenue Chart

Chart

Chart

Revenue by Segment

By Segment

Chart

• Advanced Research and Development Support Project 1.14B 78.6%
• Health Care Solution Business 312.00M 21.4%

By Geography

Chart

• Japan 1.30B 89.6%
• Europe and America 119.23M 8.2%
• Asia-Pacific 31.67M 2.2%

Fiscal year ended Jun 30, 2025 See the full TYO:6090 breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jun 30, 2026	1.42B	-34.00M	-2.34%
Jun 30, 2025	1.46B	110.00M	8.18%
Jun 30, 2024	1.35B	46.00M	3.54%
Jun 30, 2023	1.30B	76.00M	6.21%
Jun 30, 2022	1.22B	99.00M	8.81%

Data Source: S&P Global Market Intelligence Last updated: Sep 17, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 23, 2026

Data Sources Report a data error